Skip to main content
. Author manuscript; available in PMC: 2021 Apr 17.
Published in final edited form as: Neurosci Lett. 2020 Feb 27;724:134853. doi: 10.1016/j.neulet.2020.134853

Table 3.

Percent reduction in Nav1.1 and Nav1.6 peak INa from control following the perfusion of 10, 100 or 500 nM 4,9-ah-TTX. Values represent the mean ± S.E.

Reduction in Peak INa Following Perfusion of 4,9-ah-TTX
[4,9-ah-TTX] (% of Control)
Nav 1.1 N Nav 1.6 N
10nM 11 % (± 4) 4 18 % ( ±2) 4
100nM 46 % ( ± 5) 5 39 % ( ±2) 4
500 nM 64 % ( ± 4) 5 76 % ( ±2) 3